Effect of 1-(1-naphthylmethyl)-piperazine on antimicrobial agent susceptibility in multidrug-resistant isogenic and veterinary Escherichia coli field strains

Journal of Medical Microbiology

Volumn 61, Issue 6, 2012, Pages 786-792

  Marchetti, M L ^a,b   Errecalde, J ^a   Mestorino, N ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 NAPHTHYLMETHYL)PIPERAZINE; AMPICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; FLORFENICOL; PIPERAZINE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BROTH DILUTION; CONTROLLED STUDY; DAIRYING; DRUG ACTIVITY; DRUG EFFECT; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-BACTERIAL AGENTS; CARRIER STATE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENZYME INHIBITORS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MICROBIAL SENSITIVITY TESTS; PIPERAZINES;

EID: 84861144746     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.040204-0     Document Type: Article

References (33)

1. Bean, D. C. & Wareham, D. W. (2009). Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multi-drug-resistant Acinetobacter baumannii. J Antimicrob Chemother 63, 349-352.
2. Bina, X. R., Philippart, J. A. & Bina, J. E. (2009). Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-b-naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae. J Antimicrob Chemother 63, 103-108.
3. Bohnert, J. A. & Kern, W. V. (2005). Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli over-expressing RND efflux pumps. Antimicrob Agents Chemother 49, 849-852.
4. CLSI (2008). Performance Standard on Susceptibility Tests for Bacteria Isolated from Animals, 3rd edn; Approved Standard. M31-A3. Wayne, PA: Clinical and Laboratory Standards Institute.
5. CLSI (2009). Performance Standards for Antimicrobial Susceptibility Testing, 19th Informational Supplement. M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Coban, A. Y., Bayram, Z., Sezgin, F. M. & Durupinar, B. (2009). [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant Gram-negative bacteria]. Mikrobiyol Bul 43, 457-461 (in Turkish).
7. Cohen, S. P., Hächler, H. & Levy, S. B. (1993). Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. J Bacteriol 175, 1484-1492.
8. Delcour, A. (2009). Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794, 808-816.
9. Elkins, C. A. & Nikaido, H. (2002). Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J Bacteriol 184, 6490-6498.
10. Everett, M. J., Jin, Y. F., Ricci, V. & Piddock, L. J. (1996). Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40, 2380-2386.
11. George, A. M. & Levy, S. B. (1983). Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol 155, 531-540.
12. Hannula, M. & Hänninen, M. L. (2008). Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 57, 851-855.
13. Kern, W. V., Steinke, P., Schumacher, A., Schuster, S., von Baum, H. & Bohnert, J. A. (2006). Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother 57, 339-343.
14. Kriengkauykiat, J., Porter, E., Lomovskaya, O. & Wong-Beringer, A. (2005). Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49, 565-570.
15. Li, X.-Z., Zhang, L., Srikumar, R. & Poole, K. (1998). β-Lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob Agents Chemother 42, 399-403.
16. Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S. & other authors (2001). Identification and characterization of inhibitors of multi-drug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45, 105-116.
17. Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H. & Nishino, T. (2000). Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44, 3322-3327.
18. Mazzariol, A., Cornaglia, G. & Nikaido, H. (2000). Contributions of the AmpC β-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to β-lactams. Antimicrob Agents Chemother 44, 1387-1390.
19. Moreira, M., Souza, E. & Moraes, C. (2004). Multidrug efflux systems in Gram-negative bacteria. Braz J Microbiol 35, 19-28.
20. Nakae, T., Nakajima, A., Ono, T., Saito, K. & Yoneyama, H. (1999). Resistance to β-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and β-lactamase. Antimicrob Agents Chemother 43, 1301-1303.
21. Nikaido, H. (1996). Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 178, 5853-5859.
22. Nikaido, E., Yamaguchi, A. & Nishino, K. (2008). AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J Biol Chem 283, 24245-24253.
23. Office International des Epizooties (2008). Collection and Shipment of Diagnostic Specimens. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 6th edn. Paris: Office International des Epizooties.
24. Okusu, H., Ma, D. & Nikaido, H. (1996). AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 178, 306-308.
25. Pannek, S., Higgins, P. G., Steinke, P., Jonas, D., Akova, M., Bohnert, J. A., Seifert, H. & Kern, W. V. (2006). Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide. J Antimicrob Chemother 57, 970-974.
26. Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Anti-microb Chemother 56, 20-51.
27. Renau, T. E., Léger, R., Yen, R., She, M. W., Flamme, E. M., Sangalang, J., Gannon, C. L., Chamberland, S., Lomovskaya, O. & Lee, V. J. (2002). Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 12, 763-766.
28. Sáenz, Y., Ruiz, J., Zarazaga, M., Teixidó, M., Torres, C. & Vila, J. (2004). Effect of the efflux pump inhibitor Phe-Arg-β-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother 53, 544-545.
29. Schumacher, A., Steinke, P., Bohnert, J. A., Akova, M., Jonas, D. & Kern, W. V. (2006). Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother 57, 344-348.
30. Van Bambeke, F., Glupczynski, Y., Plésiat, P., Pechère, J. C. & Tulkens, P. M. (2003). Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother 51, 1055-1065.
31. Van Bambeke, F., Pages, J.-M. & Lee, V. J. (2010). Inhibitors of bacterial efflux pumps as adjuvants in antibacterial therapy and diagnostic tools for detection of resistance by efflux. Front Anti-Infect Drug Discov 1, 138-175.
32. Webber, M. A. & Piddock, L. J. (2003). The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51, 9-11.
33. Ziha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J. C. & Plesiat, P. (1999). In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob Agents Chemother 43, 287-291.